GENRÊVER Brand Site Launched — Indonesia and U.S. Business Details Now Online
A dedicated home for the GENRÊVER brand, with detailed information on GENRÊVER CLINIC in Indonesia and the Company’s Indonesia and U.S. product initiatives
Key Facts
- Company
- INSTINCT BIO TECHNICAL COMPANY HOLDINGS INC.
- Ticker
- Nasdaq: BIOT
- Announcement Date
- Category
- NEWS
- Source
- Official BIOT announcement
Now live
www.genrever.com
The official GENRÊVER brand site
INSTINCT BIO TECHNICAL COMPANY HOLDINGS INC. (Nasdaq: BIOT) (the "Company" or "Instinct Bio") today announced the launch of the official brand site for GENRÊVER, the Company’s flagship Japanese cosmetics and clinic brand, at www.genrever.com. The site brings together, in one place, the details of the Company’s GENRÊVER-related initiatives in Indonesia and the United States that were announced on July 29, July 30 and August 10, 2026 and updated in today’s press release.
Why a brand site
Until now, information on GENRÊVER has been spread across press releases and the Company’s corporate site. As the brand moves from announcement to execution — a clinic under construction in Jakarta, products in development in Indonesia, and a product line-up identified for U.S. manufacture — customers, partners and investors need a single place where the brand, its products and its locations are presented in full. The corporate site (instinct-biot.com) remains the official source for investor information and regulatory disclosures; www.genrever.com is the brand’s own home, with the depth and visual detail that a press release cannot carry.
What the site covers
・【Indonesia】GENRÊVER CLINIC — The Jakarta flagship (Gandaria, South Jakarta), the subscription model and its three monthly tiers, the planned five-city network, and the clinic’s role as the customer-facing front of the Company’s Indonesia platform.
・【Indonesia】Made in Indonesia — PARVA collaboration — The first two product candidates for the Indonesian market — a premium UV cream (SPF50+ / PA++++) and a moisturizing gel featuring HA4 — and the "Made in Indonesia, Powered by Japanese Formulation Expertise" concept behind them.
・【United States】Made in the U.S. — INVITRX collaboration — How GENRÊVER products are formulated in Japan, manufactured at INVITRX’s U.S. facility with INVITRX ingredients, and sold in the U.S. market.
・【Brand】GENRÊVER — the brand itself — The brand’s philosophy, its Japanese origin, product information, and the latest news and updates as the Indonesia and U.S. initiatives progress.
How the site relates to the Company’s disclosures
Where | What you will find
instinct-biot.com/investors(IR) | Press releases, SEC filings, stock information, investor contact. The official source for investor information.
instinct-biot.com/news(NEWS) | Detailed companion articles to each press release, in English and Japanese.
www.genrever.com(Brand) | The GENRÊVER brand, products, GENRÊVER CLINIC in Indonesia, and the Indonesia and U.S. initiatives presented in depth — the place to look for photos, product detail and brand updates.
Information on the brand site is provided for brand and product communication. Investors should rely on the Company’s press releases and SEC filings for investment decisions.
Comment from the Chairman and CEO
"GENRÊVER now has a home of its own. What we have announced in Indonesia and the United States over the past six weeks can be seen there in one place, in full — the clinic, the products and the model behind them. We will keep the site current as each initiative moves from plan to reality," said Tomoki Nagano, Chairman and Chief Executive Officer of Instinct Bio.
Related
・Press release (September 4, 2026): INSTINCT BIO Provides Operational Update on Indonesia Growth Platform and Product Development Initiatives /news/ir-operational-update-20260904
・Indonesia Growth Platform — Operational Update (detailed article) /news/indonesia-operational-update-20260904
・Product Development Progress Update: Indonesia Cosmetics Collaboration with PT PARVA CANDELA /news/parva-product-development-update-20260904
・INVITRX Collaboration Update: GENRÊVER — Made in the U.S., Sold in the U.S. /news/invitrx-us-update-20260904
About Instinct Bio
Forward-Looking Statements
INSTINCT BIO TECHNICAL COMPANY HOLDINGS INC. (Nasdaq: BIOT) is a biotechnology company focused on regenerative medicine, wellness-related technologies, and therapeutic platform development. Website: https://instinct-biot.com/
This article contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the Company’s GENRÊVER-related initiatives in Indonesia and the United States, the anticipated opening of the Jakarta clinic, product development and manufacturing timelines, and future updates to the brand site. These statements are based on current expectations and are subject to risks and uncertainties, including those described in the Company’s press releases and filings with the U.S. Securities and Exchange Commission. Actual results may differ materially. Except as required by applicable law, the Company undertakes no obligation to update them. Content on www.genrever.com is not incorporated by reference into any Company filing.
Products described are not yet available for sale unless otherwise stated. This article does not constitute an offer to sell or a solicitation of an offer to buy any securities.
Contact Information
INSTINCT BIO TECHNICAL COMPANY HOLDINGS INC.
Email: ir@instinct-bro.com
Website: https://instinct-biot.com/
Sign up for email alerts on press releases, SEC filings and events at instinct-biot.com/investors
Source Documents
Follow @BIOT_jp on X for company news and published IR updates.
